The Research Council of Norway
Support for Events (Open- ended)
NOK 3 million for events that promote health research and innovation in prevention, treatment and services from different professional perspectives.
Revelant topic: Women's health and gender perspectives in research
Financial scheme: Coordination and Support Activity
Application deadline: Open-ended
Relevant thematic areas for this call: Health
Target groups: Public sector, Industry, Research organisations
Funding scale NOK 50 000-150 000
Project duration: 1-12 months
Contact for the call: Harald Rikheim Investering og tilskuddsforvaltning hri@forskningsradet.no
National Institute of Health
Until 2027: Office of Research on Women's Health
The application amount is usually up to USD 500,000 per year. There are three annual application deadlines: February 5, June 5, and October 5, until 2027.
Contact Margarethe Bittens (University of Bergen) for more information and questions regarding application support.
Note:
Many of the previously canceled research funds are now available again after a federal judge recently overturned several directives from the central administration that led to the cancellation of the research funding. Those considering applying for funding from the NIH should stay informed through the media and the official websites for any changes in funding.
NIH: APPLY FOR RESEARCH FUNDING FOR WOMEN'S HEALTH RESEARCH:
NOT-OD-24-079: Notice of Special Interest: Womens Health Research (nih.gov)
EU Horizon relevant for research on women's health
HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
Open call under Horizon Europe (Cluster 1 – Health).
Open for submission: 10 February 2026
Deadline : 16 April 2026
HORIZON-RIA HORIZON Research and Innovation Actions
HORIZON Lump Sum Grant [HORIZON-AG-LS]
HORIZON-HLTH-2025-01-DISEASE-06 – Implementation research addressing strategies to strengthen health systems for equitable high‑quality care and health outcomes in the context of non‑communicable diseases (GACD)
Horizon Europe – Cluster 1 (Health)
- Purpose: Strengthen health systems for better, equitable treatment of NCDs
- Type: RIA, EU funding ≈ €3–4 million per project
- First-stage call: Deadline 18 September 2025; full application 16 April 2026
Read about the call on the net site European Health and Digital Executive Agency (HaDEA)
HORIZON-HLTH-2025-03-DISEASE-02 – Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders
orizon Europe – Cluster 1 (Health)
Scope: Targets mental health conditions and neurodevelopmental disorders (like ASD, ADHD), with potential links to women's health.
Funding: RIA
- €6–8 million per project
- Timeline:
- Outline proposal: 18 September 2025
- Full proposal: 16 April 2026
Read about the call on the net site EU Funding & Tenders Portal
HORIZON-HLTH-2025-01-DISEASE-07. Tackling high-burden for patients and underresearched medical conditions.
- Deadline model: single-stage
- Opening date: 22 May 2025
- Deadline date: 16 September 2025 17:00:00 Brussels time
- Funding: 6 MEUR
Scope:
A number of medical conditions fail to be recognised and/or be correctly diagnosed in a significant proportion of patients. As a consequence, they are inadequately treated and often can become a chronic and high burden for the patient. These medical conditions, including:
- myalgic encephalomyelitis/chronic fatigue syndrome,
- autism,
- gynaecological diseases,
- low back pain,
- other
may be insufficiently researched even though they manifest with high prevalence.
HORIZON-HLTH-2025-03-STAYHLTH-01- two-stage. Improving the quality of life of persons with intellectual disabilities and their families
Relevant for research on women's health as caregivers:
- Programme: HORIZON
- Call: Cluster 1 - Health (Two stage - 2025) (HORIZON-HLTH-2025-03-two-stage)
- Type of action: HORIZON-RIA HORIZON Research and Innovation Actions
- Type of MGA: HORIZON Lump Sum Grant [HORIZON-AG-LS]
- Funding: 8 MEUR
- Open For Submission
- Deadline model: two-stage
- Opening date: 22 May 2025
- Deadline dates:
- 16 September 2025 17:00:00 Brussels time
- 16 April 2026 17:00:00 Brussels time
Read more about the call on the net site
HORIZON-MISS-2025-02-CANCER-05 Pragmatic clinical trials to enhance the quality of life of older cancer patients (65 years and older) through nutrition.
Women constitute a larger proportion of older cancer patients. Gender-specific challenges in cancer treatment, the involvement of next of kin in the design of studies, and women's health research are relevant for the following call for proposals:
- Programme: Horizon Europe (HORIZON)
- Call: Supporting the implementation of the Cancer Mission (HORIZON-MISS-2025-02)
- Type of action: HORIZON-RIA HORIZON Research and Innovation Actions
- Type of MGA: HORIZON Action Grant Budget-Based [HORIZON-AG]
- Open For Submission
- Deadline model: single-stage
- Opening date: 06 May 2025
- Deadline date: 16 September 2025 17:00:00 Brussels time
- Funding: 5 MEUR
Read more about the call on the net site
Gates Foundation
Randomized Controlled Trial on Sexually Transmitted Infections (STIs) and Reproductive Tract Sequelae in Non-Pregnant Women
Initiative
Grand Challenges
Date Open
Jun 02, 2025, 11:00 am PDT
Deadline
Jul 07, 2025, 11:30 am PDT
Supporting Materials
Controlled Trials on STIs and RTIs - RFP
Controlled Trials on STIs and RTIs - Rules and Guidelines
Controlled Trials on STIs and RTIs - Application Instructions
Controlled Trials on STIs and RTIs - Frequently Asked Questions (FAQs)
Norwegian Cancer Society
Breast cancer initiatives under the annual Pink Ribbon campaign
Norwegian Cancer Society works to combat and prevent cancer, and to ensure that cancer patients and their next of kin have the best possible life. The Cancer Society allocates funds for research projects within these thematic areas, including breast cancer initiatives under the Pink Ribbon campaign.
Stay tuned to the Cancer Society's website and announcements for their annual main call for proposals to learn more about the 2026 Pink Ribbon funds.
European Partnership for Personalised Medicine
Joint Transnational Call 2026 under EP PerMed
Personalized medicine for cardiovascular, metabolic and kidney disease. Factors such as sex/gender may be included as variables in analyses, but it is not a requirement or main objective for the research to focus on women’s health
ERA4Health
Transnational research call under ERA4Health
https://era4health.eu/calls/preventoo2026.php
The call focuses on understanding and prevention of overweight and obesity, not explicitly on general women’s health research, but it includes topics such as critical life transition periods like menopause and postpartum, which may be relevant for women’s health research.
Novo Nordisk Foundation
Female Heart - Mechanistic Research Grants
Female Heart - Mechanistic Research Grants is a funding call from the Novo Nordisk Foundation that supports research into the biological mechanisms underlying sex differences in cardiovascular disease. The aim is to strengthen understanding of why these diseases manifest differently in women through international collaboration anchored in the Nordic countries.
Application deadline: 19 March 2026
Funding: Total funding of up to DKK 75 million, with up to DKK 15 million per project for a 4-year research period.
Female Heart – Mechanistic Research Grants - Novo Nordisk Fonden
Female Heart - Clinical Research Grants
Female Heart – Clinical Research Grants is a funding call from the Novo Nordisk Foundation that supports clinical research on sex differences in cardiovascular disease, with a particular focus on conditions that affect or present differently in women.
Application deadline: 19 March 2026
Funding: Total funding of up to DKK 75 million, with up to DKK 15 million per project for a 4-year research period.
Female Heart – Clinical Research Grants - Novo Nordisk Fonden